Advate

Advaite is a biotechnology company headquartered in Malvern, Pennsylvania, focused on developing next-generation personalized diagnostics and therapeutics. The company gained significant prominence for its RapCov Rapid COVID-19 Test, a point-of-care lateral flow assay designed to detect IgG antibodies to the SARS-CoV-2 spike protein. Beyond infectious diseases, Advaite is leveraging its expertise to develop novel oncology solutions, including therapeutics and diagnostics targeting Carbonic Anhydrase IX (CAIX) for difficult-to-treat cancers like pancreatic cancer. The company aims to bridge the gap between complex laboratory testing and rapid, actionable medical results to improve patient outcomes globally.